List of works - David A Power

AMP‐activated protein kinase isoenzyme family: subunit structure and chromosomal location ⬇️

scientific article (publication date: 16 June 1997)

Absence of the β1 subunit of AMP-activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetes

scientific article published on 26 April 2019

Complex organisation of the 5′-end of the human glycine tRNA synthetase gene ⬇️

scientific article published on March 16, 1998

Cyclosporin A and the humoral response to blood transfusion in the rat: definition of antigens which suppress alloantibody formation ⬇️

scientific article published on 01 January 1991

Cyclosporin a prevents sensitization after blood transfusion in multiparous rats ⬇️

scientific article published on 01 April 1988

Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C]leucine

scientific article published on January 1, 1992

Epstein-Barr virus-transformed oligoclonal B cell lines producing a cytotoxic human autoantibody ⬇️

scientific article published on March 1, 1991

Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy ⬇️

scientific article published on 01 May 1998

Importance of the tubulointerstitium in human glomerulonephritis. II. Distribution of integrin chains β1, α1 to 6 and αV ⬇️

scientific article published on 01 July 1997

Malignant Hypertension Causing a Pulmonary-Renal Syndrome

scientific article published on 17 December 2018

Monoclonal antibodies to cultured human glomerular mesangial cells. I. Reactivity with haematopoietic cells and normal kidney sections ⬇️

scientific article published on 01 March 1991

Possible mechanism of action of transfusion effect in renal transplantation ⬇️

scientific article published on August 28, 1982

Pre-eclampsia is associated with altered expression of the renal sodium transporters NKCC2, NCC and ENaC in urinary extracellular vesicles

scientific article published in PLoS ONE

The Effect of Cyclosporin Administered During a Third-Party Blood Transfusion Protocol on Humoral Immune Responses ⬇️